Freakonomics Radio
We all want to stay sharp, and forestall the cognitive effects of aging. But do brain supplements actually work? Are they safe? And why doesn’t the F.D.A. even know what’s in them? (Part one of “The Freakonomics Radio Guide to Getting Better.”)
- SOURCES:
- Marty Makary, commissioner of the Food and Drug Administration.
- Peter Attia, physician, author, and host of The Peter Attia Drive.
- Pieter Cohen, associate professor of medicine at Harvard Medical School, physician at the Cambridge Health Alliance.
- RESOURCES:
- “Protein Powders and Shakes Contain High Levels of Lead,” by Paris Martineau (Consumer Reports, 2025).
- “Accuracy of Labeling of Galantamine Generic Drugs and Dietary Supplements,” by Pieter Cohen, Bram Jacobs, Koenraad Van Hoorde, and Céline Vanhee (JAMA, 2024).
- Blind Spots: When Medicine Gets It Wrong, and What It Means for Our Health, by Marty Makary (2024).
- Outlive: The Science and Art of Longevity, by Petter Attia (2023).
- “Revealing the hidden dangers of dietary supplements,” by Jennifer Couzin-Frankel (Science, 2015).
- EXTRAS:
- “China Is Run by Engineers. America Is Run by Lawyers.” by Freakonomics Radio (2025).
- “How to Fix the Hot Mess of U.S. Healthcare,” by Freakonomics Radio (2021).
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
EXTRA: People Aren’t Dumb. The World Is Hard. (Update)
You wouldn’t think you could win a Nobel Prize for showing that humans tend to make irrational decisions. But that’s what Richard Thaler has done. In an interview from 2018, the founder of behavioral economics…
596. Farewell to a Generational Talent
Daniel Kahneman left his mark on academia (and the real world) in countless ways. A group of his friends and colleagues recently gathered in Chicago to reflect on this legacy — and we were there,…
595. Why Don’t We Have Better Candidates for President?
American politics is trapped in a duopoly, with two all-powerful parties colluding to stifle competition. We revisit a 2018 episode to explain how the political industry works, and talk to a reformer (and former presidential…
594. Your Brand’s Spokesperson Just Got Arrested — Now What?
It’s hard to know whether the benefits of hiring a celebrity are worth the risk. We dig into one gruesome story of an endorsement gone wrong, and find a surprising result. SOURCES: John Cawley,…
593. You Can Make a Killing, but Not a Living
Broadway operates on a winner-take-most business model. A runaway hit like Stereophonic — which just won five Tony Awards — will create a few big winners. But even the stars of the show will have…
EXTRA: The Fascinatingly Mundane Secrets of the World’s Most Exclusive Nightclub
The Berlin dance mecca Berghain is known for its eight-hour line and inscrutable door policy. PJ Vogt, host of the podcast Search Engine, joins us to crack the code. It has to do with Cold…
592. How to Make the Coolest Show on Broadway
Hit by Covid, runaway costs, and a zillion streams of competition, serious theater is in serious trouble. A new hit play called Stereophonic — the most Tony-nominated play in history — has something to say…
591. Signs of Progress, One Year at a Time
Every December, a British man named Tom Whitwell publishes a list of 52 things he’s learned that year. These fascinating facts reveal the spectrum of human behavior, from fraud and hypocrisy to Whitwell’s steadfast belief…
EXTRA: The Opioid Tragedy — How We Got Here
An update of our 2020 series, in which we spoke with physicians, researchers, and addicts about the root causes of the crisis — and the tension between abstinence and harm reduction. SOURCES: Gail D’Onofrio, professor…
590. Can $55 Billion End the Opioid Epidemic?
Thanks to legal settlements with drug makers and distributors, states have plenty of money to boost prevention and treatment. Will it work? (Part two of a two-part series.) SOURCES: Keith Humphreys, professor of psychiatry…